About
Swedish Orphan Biovitrum Ab (publ) (PINK:BIOVF) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 9 2026
Sobi Receives Health Canada Approval for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
Mar 31 2026
Sobi publishes Annual and Sustainability Report for 2025
Mar 27 2026
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
Feb 18 2026
Sobi Capital Markets Day 2026: Bringing brilliant ideas to life and building the next chapter with ambition to deliver SEK 55bn by 2030
Feb 11 2026
Sobi to host a Capital Markets Day on 18 February 2026
Google Übersetzer